| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2663 | 2019 |
| Long-term persistence of hormonal adaptations to weight loss P Sumithran, LA Prendergast, E Delbridge, K Purcell, A Shulkes, ... New England Journal of Medicine 365 (17), 1597-1604, 2011 | 1824 | 2011 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 616 | 2019 |
| Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation I Lingvay, P Sumithran, RV Cohen, CW le Roux The Lancet 399 (10322), 394-405, 2022 | 451 | 2022 |
| Ketosis and appetite-mediating nutrients and hormones after weight loss P Sumithran, LA Prendergast, E Delbridge, K Purcell, A Shulkes, ... European journal of clinical nutrition 67 (7), 759-764, 2013 | 424 | 2013 |
| The defence of body weight: a physiological basis for weight regain after weight loss P Sumithran, J Proietto Clinical Science 124 (4), 231-241, 2013 | 385 | 2013 |
| Contemporary medical, device, and surgical therapies for obesity in adults CM Perdomo, RV Cohen, P Sumithran, K Clément, G Frühbeck The Lancet 401 (10382), 1116-1130, 2023 | 346 | 2023 |
| The effect of rate of weight loss on long-term weight management: a randomised controlled trial K Purcell, P Sumithran, LA Prendergast, CJ Bouniu, E Delbridge, ... The Lancet Diabetes & Endocrinology 2 (12), 954-962, 2014 | 277 | 2014 |
| Ketogenic diets for weight loss: a review of their principles, safety and efficacy P Sumithran, J Proietto Obesity Research & Clinical Practice 2 (1), 1-13, 2008 | 125 | 2008 |
| Comparing video-based, telehealth-delivered exercise and weight loss programs with online education on outcomes of knee osteoarthritis: a randomized trial KL Bennell, BJ Lawford, C Keating, C Brown, J Kasza, D Mackenzie, ... Annals of internal medicine 175 (2), 198-209, 2022 | 91 | 2022 |
| Treatment of obesity in older persons—a systematic review C Haywood, P Sumithran Obesity Reviews 20 (4), 588-598, 2019 | 88 | 2019 |
| Benefit-risk assessment of orlistat in the treatment of obesity P Sumithran, J Proietto Drug safety 37, 597-608, 2014 | 70 | 2014 |
| A review of sex differences in the mechanisms and drivers of overeating RG Anversa, M Muthmainah, D Sketriene, A Gogos, P Sumithran, ... Frontiers in neuroendocrinology 63, 100941, 2021 | 43 | 2021 |
| Clinical obesity services in public hospitals in Australia: a position statement based on expert consensus E Atlantis, N Kormas, K Samaras, P Fahey, P Sumithran, S Glastras, ... Clinical obesity 8 (3), 203-210, 2018 | 43 | 2018 |
| Potential gut–brain mechanisms behind adverse mental health outcomes of bariatric surgery RM Brown, E Guerrero-Hreins, WA Brown, CW le Roux, P Sumithran Nature Reviews Endocrinology 17 (9), 549-559, 2021 | 42 | 2021 |
| Obesity in adults I Lingvay, RV Cohen, CW le Roux, P Sumithran The Lancet 404 (10456), 972-987, 2024 | 39 | 2024 |
| Preconception management of women with obesity: a systematic review SA Price, P Sumithran, A Nankervis, M Permezel, J Proietto Obesity Reviews 20 (4), 510-526, 2019 | 39 | 2019 |
| Safe year-long use of a very-low-calorie diet for the treatment of severe obesity P Sumithran, J Proietto The Medical Journal of Australia 188 (6), 366-368, 2008 | 38 | 2008 |
| Combination phentermine and topiramate for weight maintenance: the first Australian experience SL Neoh, P Sumithran, CJ Haywood, CA Houlihan, FTH Lee, J Proietto Medical Journal of Australia 201 (4), 224-226, 2014 | 36 | 2014 |
| Identifying stress-related eating in behavioural research: A review L Stammers, L Wong, R Brown, S Price, E Ekinci, P Sumithran Hormones and behavior 124, 104752, 2020 | 35 | 2020 |
